# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001232524-25-000027
Filing Date
2025-05-07
Accepted
2025-05-07 07:33:48
Documents
88
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | jazz-20250331.htm iXBRL | 10-Q | 1468252
2 | SUPPLY AGREEMENT | jazzq12025ex102.htm | EX-10.2 | 235922
3 | EXECUTIVE COMMITTEE SEVERANCE BENEFIT PLAN | jazzq12025ex104.htm | EX-10.4 | 231665
4 | CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) | jazzq12025ex311.htm | EX-31.1 | 10273
5 | CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) | jazzq12025ex312.htm | EX-31.2 | 10348
6 | CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 | jazzq12025ex321.htm | EX-32.1 | 7019
| Complete submission text file | 0001232524-25-000027.txt |  | 8534974

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | jazz-20250331.xsd | EX-101.SCH | 55131
8 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | jazz-20250331_cal.xml | EX-101.CAL | 95869
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | jazz-20250331_def.xml | EX-101.DEF | 269507
10 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | jazz-20250331_lab.xml | EX-101.LAB | 690484
11 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | jazz-20250331_pre.xml | EX-101.PRE | 482384
91 | EXTRACTED XBRL INSTANCE DOCUMENT | jazz-20250331_htm.xml | XML | 1151479

Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 25919302
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)